推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Highly skewed T-cell receptor V-beta chain repertoire in the bone marrow is associated with response to immunosuppressive drug therapy in children with very severe …

FR Schuster, B Hubner, M Führer… - Blood Cancer …, 2011 - nature.com
One of the major obstacles of immunosuppressive therapy (IST) in children with severe aplastic
anemia (SAA) comes from the often months-long unpredictability of bone-marrow (BM)
recovery. In this prospective study in children with newly diagnosed very severe AA ...
Related articles

Protective effect of intravitreal administration of Tresperimus, an immunosuppressive drug, on experimental autoimmune uveoretinitis

E Bousquet, S Camelo, G Leroux les Jardins… - … Ophthalmology & Visual …, 2011 - ARVO
... Protective effect of intravitreal administration of Tresperimus, an immunosuppressive drug, on
experimental autoimmune uveoretinitis ... Tresperimus is an immunosuppressive drug structurally
related to deoxyspergualin (DSG), which was initially developed as an antitumor agent. ...
Related articles - All 2 versions

[PDF] Impact of Sirolimus Versus Cyclosporin A Immunosuppressive Drug in Dog's Alveolar Bone

[PDF] from jofamericanscience.orgME Helal… - Journal of American Science, 2011 - jofamericanscience.org
Abstract: Sirolimus is a modern immunosuppressive drug that has a novel mechanism of action
as it improves the patients' condition receiving transplant. This study aimed to asses the effects
of sirolimus Vs cyclosporin A (CsA) immunosuppressive drug on teeth's alveolar bone. ...
Related articles - View as HTML

Linking molecular feature space and disease terms for the immunosuppressive drug rapamycin

A Bernthaler, K Mönks, I Mühlberger… - Molecular …, 2011 - pubs.rsc.org
Next to development of novel drugs also drug repositioning appears promising for tackling unmet
clinical needs. Here Omics provided the ground for novel analysis strategies for linking drug
and disease by integrating profiles on the molecular as well as the clinical data level. We ...

Th17 Cells in Alemtuzumab-Treated Patients: The Effect of Long-Term Maintenance Immunosuppressive Therapy

J Hester, N Mills, S Shankar… - …, 2011 - journals.lww.com
... Although advances in immunosuppressive drug regimens over the last decades have led to
significant improvement in 1-year transplant outcome ( 1 ), managing subclinical destructive
processes leading to graft dysfunction and chronic rejection remains a major clinical ...
Cited by 2 - Related articles - All 4 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451